ProtoKinetix, Incorporated (OTCMKTS:PKTX) Sees Large Decline in Short Interest

ProtoKinetix, Incorporated (OTCMKTS:PKTX) was the target of a large decrease in short interest during the month of February. As of February 15th, there was short interest totalling 400 shares, a decrease of 96.0% from the January 31st total of 10,000 shares. Based on an average daily volume of 408,500 shares, the short-interest ratio is presently 0.0 days.

ProtoKinetix Price Performance

Shares of PKTX stock traded up $0.00 during trading hours on Friday, reaching $0.01. The company’s stock had a trading volume of 241,181 shares, compared to its average volume of 177,778. ProtoKinetix has a one year low of $0.01 and a one year high of $0.02. The firm’s fifty day simple moving average is $0.01 and its 200 day simple moving average is $0.01.

About ProtoKinetix

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.